FDA approves single REMS for transmucosal immediate-release fentanyl products
The U.S. Food and Drug Administration has approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release…
REMS
FDA publishes REMS list
Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read…
